VivoSim Labs, Inc.
VIVS
$1.80
-$0.06-3.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.00K | 28.00K | 37.00K | 51.00K | 24.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.00K | 28.00K | 37.00K | 51.00K | 24.00K |
| Cost of Revenue | 1.14M | 923.00K | 1.00M | 859.00K | 1.78M |
| Gross Profit | -1.11M | -895.00K | -964.00K | -808.00K | -1.76M |
| SG&A Expenses | 1.64M | 1.74M | 1.95M | 2.35M | 1.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.78M | 2.66M | 2.95M | 3.21M | 3.49M |
| Operating Income | -2.75M | -2.64M | -2.92M | -3.15M | -3.47M |
| Income Before Tax | -2.69M | -2.54M | -2.84M | 6.85M | -3.45M |
| Income Tax Expenses | -- | 2.00K | -- | 0.00 | -- |
| Earnings from Continuing Operations | -2.69M | -2.55M | -2.84M | 6.85M | -3.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.69M | -2.55M | -2.84M | 6.85M | -3.45M |
| EBIT | -2.75M | -2.64M | -2.92M | -3.15M | -3.47M |
| EBITDA | -2.70M | -2.58M | -2.85M | -3.09M | -3.40M |
| EPS Basic | -1.03 | -0.98 | -1.14 | 4.21 | -2.29 |
| Normalized Basic EPS | -0.64 | -0.61 | -0.71 | -1.21 | -1.43 |
| EPS Diluted | -1.03 | -0.98 | -1.14 | 4.21 | -2.29 |
| Normalized Diluted EPS | -0.64 | -0.61 | -0.71 | -1.21 | -1.43 |
| Average Basic Shares Outstanding | 2.61M | 2.61M | 2.50M | 1.63M | 1.50M |
| Average Diluted Shares Outstanding | 2.61M | 2.61M | 2.50M | 1.63M | 1.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |